LINCIANO, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 779
EU - Europa 452
AS - Asia 108
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 1
Totale 1.345
Nazione #
US - Stati Uniti d'America 779
IE - Irlanda 294
CN - Cina 89
IT - Italia 55
FI - Finlandia 52
DE - Germania 23
AT - Austria 9
BE - Belgio 9
SG - Singapore 8
EU - Europa 5
IN - India 5
FR - Francia 3
HK - Hong Kong 2
SI - Slovenia 2
TR - Turchia 2
CZ - Repubblica Ceca 1
EC - Ecuador 1
IL - Israele 1
NL - Olanda 1
PH - Filippine 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 1.345
Città #
Dublin 294
Chandler 257
Ashburn 130
Shanghai 63
Helsinki 52
New York 29
Pavia 24
Lawrence 23
Medford 23
Princeton 23
Seattle 21
Wilmington 16
Washington 13
Brussels 9
Vienna 8
Beijing 6
Boardman 6
Los Angeles 6
Singapore 6
Bolzaneto 5
Chicago 5
Pune 5
Woodbridge 5
Ann Arbor 3
Norwalk 3
Torino 3
Fairfield 2
Florence 2
Guiyang 2
Houston 2
Istanbul 2
Murska Sobota 2
Piscataway 2
Reggio Emilia 2
Rome 2
Rozzano 2
Turin 2
West Jordan 2
Andover 1
Atlanta 1
Ballabio 1
Berlin 1
Bologna 1
Bratislava 1
Braunschweig 1
Brno 1
Chengdu 1
Citta 1
Englewood 1
Falkenstein 1
Fuzhou 1
Gunzenhausen 1
Jacksonville 1
Milan 1
Nanchang 1
Omaha 1
Padova 1
Palermo 1
Paris 1
Phoenix 1
Quito 1
Redmond 1
Shenyang 1
Stockholm 1
Ugong Norte 1
Varese 1
Totale 1.090
Nome #
Effects of Bisphenols on RACK1 Expression and Their Immunological Implications in THP-1 Cells 45
Identification of a Potent and Selective 5-HT1AReceptor Agonist with in Vitro and in Vivo Antinociceptive Activity 43
Identification of N,N-arylalkyl-picolinamide derivatives targeting the RNA-binding protein HuR, by combining biophysical fragment-screening and molecular hybridization 43
4-Amino-1,2,4-triazole-3-thione as a Promising Scaffold for the Inhibition of Serine and Metallo-β-Lactamases 40
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 38
Microwave-Assisted Extraction and HPLC-UV-CD Determination of (S)-usnic Acid in Cladonia foliacea 37
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign 36
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 36
Chiral 2-phenyl-3-hydroxypropyl esters as PKC-alpha modulators: HPLC enantioseparation, NMR absolute configuration assignment, and molecular docking studies 36
Tackling Antimicrobial Resistance with Small Molecules Targeting LsrK: Challenges and Opportunities 35
Evidence of pyrimethamine and cycloguanil analogues as dual inhibitors of trypanosoma brucei pteridine reductase and dihydrofolate reductase 35
Sigma-1 receptor antagonists: promising players in fighting neuropathic pain 34
Sigma-1 receptor agonists acting on aquaporin-mediated h2o2 permeability: New tools for counteracting oxidative stress 34
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 32
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 31
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 30
An Improved Synthesis of CENTA, a Chromogenic Substrate for β-Lactamases 30
Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist 29
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 29
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R) 28
Investigation of the effect of different linker chemotypes on the inhibition of Histone Deacetylases (HDACs) 28
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 27
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 27
EFFECTS OF ENDOCRINE ACTIVE CONTAMINATING PESTICIDES ON RACK1 EXPRESSION AND IMMUNOLOGICAL CONSEQUENCES IN THP-1 CELLS 26
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 26
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor 26
Origin of Δ9-Tetrahydrocannabinol Impurity in Synthetic Cannabidiol 26
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth 25
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design 25
A multidisciplinary approach to the design of novel inhibitors for KPC-2 23
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 23
New weapons against antimicrobial resistance: 
Targeting SOS response to recover b
 actericidal activity of antibiotics
 22
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 22
Is cannabidiol a scheduled controlled substance? Origin makes the difference 22
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 21
Development of therapeutic agents blocking SOS activation 20
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 19
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 18
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 17
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics 15
Structural Insights into the Ligand-LsrK Kinase Binding Mode: A Step Forward in the Discovery of Novel Antimicrobial Agents 15
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 15
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 15
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells 11
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 10
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 9
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 9
Structural development studies of PPARs ligands based on tyrosine scaffold 8
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer 8
Urea-based anticancer agents. Exploring 100-years of research with an eye to the future 7
Excited-state intramolecular proton transfer in a bioactive flavonoid provides fluorescence observables for recognizing its engagement with target proteins 7
Phenyl boronic acids development led to validated leads active in clinical strains overexpressing KPC-2: a step against bacterial resistance 7
Sigma receptor and aquaporin modulators: chiral resolution, configurational assignment, and preliminary biological profile of RC752 enantiomers 7
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 6
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors 6
First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase 6
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 6
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain 6
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 6
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era 6
Short- and Long-Term Regulation of HuD: A Molecular Switch Mediated by Folic Acid? 6
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 6
Identification of a novel extracellular inhibitor of FGF2/FGFR signaling axis by combined virtual screening and NMR spectroscopy approach 6
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 5
Phenylboronic Acids Probing Molecular Recognition against Class A and Class C beta-Lactamases 5
Evolving Challenges and Opportunities in Plant-based Drug Discovery and Development 5
In silico identification and experimental validation of hits active against KPC-2 β-lactamase 5
Neurodegeneration: can metabolites from Eremurus persicus help? 4
Sigma receptor and aquaporin modulators: chiral resolution, configurational assignment, and preliminary biological profile of RC752 enantiomers 4
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1 4
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 4
Use of primary amines for the selective N-Alkylation of anilines by a reusable heterogeneous catalyst 4
Optimization of N-alkylation in the Synthesis of Methotrexate and Pteridine-based Derivatives Under Microwave-Irradiation 4
Identification of HuR-RNA Interfering Compounds by Dynamic Combinatorial Chemistry and Fluorescence Polarization 2
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 2
Biophysical Assays for Investigating Modulators of Macromolecular Complexes: An Overview 1
Totale 1.396
Categoria #
all - tutte 8.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 17 3 0 4 4 4 0 0 0
2021/2022120 0 0 16 0 1 3 1 13 2 4 22 58
2022/2023729 33 45 14 65 56 76 0 47 341 9 27 16
2023/2024506 23 92 21 27 34 124 63 40 6 21 22 33
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.396